Ping An Biomedical Financials
This page shows Ping An Biomedical (PASW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
For every $1 of reported earnings, Ping An Biomedical generates $0.50 in operating cash flow (-$903K OCF vs -$1.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Ping An Biomedical earns $-47.9 in operating income for every $1 of interest expense (-$2.1M vs $43K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Ping An Biomedical generated $4.8M in revenue in fiscal year 2025.
Ping An Biomedical's EBITDA was -$2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Ping An Biomedical reported -$1.8M in net income in fiscal year 2025.
Ping An Biomedical held $165K in cash against $0 in long-term debt as of fiscal year 2025.
Ping An Biomedical had 21M shares outstanding in fiscal year 2025.
Ping An Biomedical's gross margin was 2.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.
Ping An Biomedical's operating margin was -43.0% in fiscal year 2025, reflecting core business profitability.
Ping An Biomedical's net profit margin was -37.6% in fiscal year 2025, showing the share of revenue converted to profit.
PASW Income Statement
| Metric | Q3'25 | Q2'25 |
|---|---|---|
| Revenue | N/A | N/A |
| Cost of Revenue | N/A | N/A |
| Gross Profit | N/A | N/A |
| R&D Expenses | N/A | N/A |
| SG&A Expenses | N/A | N/A |
| Operating Income | N/A | N/A |
| Interest Expense | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income | N/A | N/A |
| EPS (Diluted) | N/A | N/A |
PASW Balance Sheet
| Metric | Q3'25 | Q2'25 |
|---|---|---|
| Total Assets | $9.6M+43.4% | $6.7M |
| Current Assets | $8.9M+40.9% | $6.3M |
| Cash & Equivalents | $165K+990.0% | $15K |
| Inventory | $62K+240.4% | $18K |
| Accounts Receivable | $2.4M-42.5% | $4.1M |
| Goodwill | N/A | N/A |
| Total Liabilities | $3.3M-60.9% | $8.3M |
| Current Liabilities | $3.2M-60.8% | $8.3M |
| Long-Term Debt | N/A | N/A |
| Total Equity | $6.4M+492.6% | -$1.6M |
| Retained Earnings | -$3.0M-72.3% | -$1.7M |
PASW Cash Flow Statement
| Metric | Q3'25 | Q2'25 |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Investing Cash Flow | N/A | N/A |
| Financing Cash Flow | N/A | N/A |
| Dividends Paid | N/A | N/A |
| Share Buybacks | N/A | N/A |
PASW Financial Ratios
| Metric | Q3'25 | Q2'25 |
|---|---|---|
| Gross Margin | N/A | N/A |
| Operating Margin | N/A | N/A |
| Net Margin | N/A | N/A |
| Return on Equity | N/A | N/A |
| Return on Assets | N/A | N/A |
| Current Ratio | 2.76+2.0 | 0.77 |
| Debt-to-Equity | 0.51+5.7 | -5.14 |
| FCF Margin | N/A | N/A |
Frequently Asked Questions
What is Ping An Biomedical's annual revenue?
Ping An Biomedical (PASW) reported $4.8M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Ping An Biomedical profitable?
No, Ping An Biomedical (PASW) reported a net income of -$1.8M in fiscal year 2025, with a net profit margin of -37.6%.
What is Ping An Biomedical's earnings per share (EPS)?
Ping An Biomedical (PASW) reported diluted earnings per share of $-0.10 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Ping An Biomedical's EBITDA?
Ping An Biomedical (PASW) had EBITDA of -$2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Ping An Biomedical's gross margin?
Ping An Biomedical (PASW) had a gross margin of 2.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ping An Biomedical's operating margin?
Ping An Biomedical (PASW) had an operating margin of -43.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ping An Biomedical's net profit margin?
Ping An Biomedical (PASW) had a net profit margin of -37.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ping An Biomedical's operating cash flow?
Ping An Biomedical (PASW) generated -$903K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ping An Biomedical's total assets?
Ping An Biomedical (PASW) had $9.6M in total assets as of fiscal year 2025, including both current and long-term assets.
How many shares does Ping An Biomedical have outstanding?
Ping An Biomedical (PASW) had 21M shares outstanding as of fiscal year 2025.
What is Ping An Biomedical's current ratio?
Ping An Biomedical (PASW) had a current ratio of 2.76 as of fiscal year 2025, which is generally considered healthy.
What is Ping An Biomedical's debt-to-equity ratio?
Ping An Biomedical (PASW) had a debt-to-equity ratio of 0.51 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ping An Biomedical's return on assets (ROA)?
Ping An Biomedical (PASW) had a return on assets of -18.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ping An Biomedical's cash runway?
Based on fiscal year 2025 data, Ping An Biomedical (PASW) had $165K in cash against an annual operating cash burn of $903K. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Are Ping An Biomedical's earnings high quality?
Ping An Biomedical (PASW) has an earnings quality ratio of 0.50x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ping An Biomedical cover its interest payments?
Ping An Biomedical (PASW) has an interest coverage ratio of -47.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.